Monge A - Search Results

1

New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.

Martínez-Esparza J, Oficialdegui AM, Pérez-Silanes S, Heras B, Orús L, Palop JA, Lasheras B, Roca J, Mourelle M, Bosch A, Del Castillo JC, Tordera R, Del Río J, Monge A. Martínez-Esparza J, et al. Among authors: monge a. J Med Chem. 2001 Feb 1;44(3):418-28. doi: 10.1021/jm001059j. J Med Chem. 2001. PMID: 11462981

2

New 5-hydroxy-2-indolecarbohydrazides as platelet aggregation inhibitors in ethylene glycol.

Monge A, Genua I, Palop JA, Martinez MT, Roldan F, Fernández J. Monge A, et al. J Pharm Sci. 1978 Jul;67(7):1025-7. doi: 10.1002/jps.2600670744. J Pharm Sci. 1978. PMID: 660494

3

Antihypertensive and vasodilator effect of A-80b, a new pyridazino indole derivative.

Frechilla D, Bernedo E, Castiella E, Lasheras B, Cenarruzabeitia E, Monge A, Aldana I, Alvarez T, Losa MJ, Font M. Frechilla D, et al. Among authors: monge a. Eur J Pharmacol. 1992 Sep 4;219(3):409-14. doi: 10.1016/0014-2999(92)90482-j. Eur J Pharmacol. 1992. PMID: 1425969

4

New 5H-pyridazino[4,5-b]indole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation and inotropics.

Monge A, Aldana I, Alvarez T, Font M, Santiago E, Latre JA, Bermejillo MJ, Lopez-Unzu MJ, Fernandez-Alvarez E. Monge A, et al. J Med Chem. 1991 Oct;34(10):3023-9. doi: 10.1021/jm00114a010. J Med Chem. 1991. PMID: 1656043

5

Hypoxia-selective agents derived from 2-quinoxalinecarbonitrile 1,4-di-N-oxides. 2.

Monge A, Martínez-Crespo FJ, López de Ceráin A, Palop JA, Narro S, Senador V, Marín A, Sainz Y, González M, Hamilton E, et al. Monge A, et al. J Med Chem. 1995 Oct 27;38(22):4488-94. doi: 10.1021/jm00022a014. J Med Chem. 1995. PMID: 7473576

6

Pharmacological characterization of the vasodilator effect of DF-100, a new pyridazino[4,5-b]indole, in vascular smooth muscle.

Frechilla D, Castiella E, Lasheras B, Cenarruzabeitia E, Monge A, Aldana I, Alvarez T, Losa MJ, Font M. Frechilla D, et al. Among authors: monge a. J Cardiovasc Pharmacol. 1993 Jan;21(1):89-94. doi: 10.1097/00005344-199301000-00013. J Cardiovasc Pharmacol. 1993. PMID: 7678685

7

Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.

Monge A, Palop JA, López de Ceráin A, Senador V, Martínez-Crespo FJ, Sainz Y, Narro S, García E, de Miguel C, González M, et al. Monge A, et al. J Med Chem. 1995 May 12;38(10):1786-92. doi: 10.1021/jm00010a023. J Med Chem. 1995. PMID: 7752202

8

The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.

Artaiz I, Romero G, Zazpe A, Monge A, Calderó JM, Roca J, Lasheras B, Del Río J. Artaiz I, et al. Among authors: monge a. Psychopharmacology (Berl). 1995 Jan;117(2):137-48. doi: 10.1007/BF02245179. Psychopharmacology (Berl). 1995. PMID: 7753959

9

Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.

Monge A, Peña MC, Palop JA, Calderó JM, Roca J, García E, Romero G, del Río J, Lasheras B. Monge A, et al. J Med Chem. 1994 Apr 29;37(9):1320-5. doi: 10.1021/jm00035a012. J Med Chem. 1994. PMID: 8176710

10

Novel antagonists of 5-HT3 receptors. Synthesis and biological evaluation of piperazinylquinoxaline derivatives.

Monge A, Palop JA, Del Castillo JC, Calderó JM, Roca J, Romero G, Del Río J, Lasheras B. Monge A, et al. J Med Chem. 1993 Sep 17;36(19):2745-50. doi: 10.1021/jm00071a005. J Med Chem. 1993. PMID: 8410988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page